Orphazyme didn't know buyer before negotiations began

Orphazyme, a listed company in Denmark that has been restructuring since in March, did not have any superficial knowledge of its potentially new US-based owner, Kempharm, before entering negotiations.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme sells entire business to US biotech company
For subscribers